Literature DB >> 14872081

Randomisation in trials: do potential trial participants understand it and find it acceptable?

C Kerr1, E Robinson, A Stevens, D Braunholtz, S Edwards, R Lilford.   

Abstract

OBJECTIVE: To examine lay persons' ability to identify methods of random allocation and their acceptability of using methods of random allocation in a clinical trial context.
DESIGN: Leaflets containing hypothetical medical, non-medical, and clinical trial scenarios involving random allocation, using material from guidelines for trial information leaflets. SETTING AND PARTICIPANTS: Adults attending further education colleges (n = 130), covering a wide range of ages, occupations, and levels of education. MAIN MEASURES: Judgements of whether each of five methods of allocation to two groups was random in a medical or non-medical scenario. Judgements of whether these allocation methods were acceptable in a randomised clinical trial scenario, with or without a scientific justification for randomisation.
RESULTS: The majority of our group of participants judged correctly that allowing people their preference was not random, and that the following were random: using a computer with no information about the individual (recommended wording for MREC trial leaflets), tossing a coin, drawing a name out of a hat. Judgements were split over allocating people in turn (not a random allocation method but shares features with randomisation). Judgements were no different in medical and non-medical scenarios. Few of the correctly identified random methods were judged to be acceptable in a clinical trial scenario. Inclusion of a scientific justification for randomising significantly increased the acceptability of only one random method: allocation by computer.
CONCLUSIONS: Current UK guidelines' recommended description of random allocation by computer seems warranted. However, while potential trial participants may understand what random allocation means, they may find it unacceptable unless offered an acceptable justification for its use.

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach

Mesh:

Year:  2004        PMID: 14872081      PMCID: PMC1757143          DOI: 10.1136/jme.2002.001123

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  10 in total

Review 1.  Ethical issues in the design and conduct of randomised controlled trials.

Authors:  S J Edwards; R J Lilford; D A Braunholtz; J C Jackson; J Hewison; J Thornton
Journal:  Health Technol Assess       Date:  1998-12       Impact factor: 4.014

2.  Who understands? A survey of 25 words or phrases commonly used in proposed clinical research consent forms.

Authors:  William C Waggoner; Diane M Mayo
Journal:  IRB       Date:  1995 Jan-Feb

3.  Do you understand?: an ethical assessment of researchers' description of the consenting process.

Authors:  S L Titus; M A Keane
Journal:  J Clin Ethics       Date:  1996

4.  False hopes and best data: consent to research and the therapeutic misconception.

Authors:  P S Appelbaum; L H Roth; C W Lidz; P Benson; W Winslade
Journal:  Hastings Cent Rep       Date:  1987-04       Impact factor: 2.683

5.  Equipoise and the ethics of clinical research.

Authors:  B Freedman
Journal:  N Engl J Med       Date:  1987-07-16       Impact factor: 91.245

6.  Offering patients entry in clinical trials: preliminary study of the views of prospective participants.

Authors:  F Corbett; J Oldham; R Lilford
Journal:  J Med Ethics       Date:  1996-08       Impact factor: 2.903

7.  Patients' perceptions on informed consent and the quality of information disclosure in clinical trials.

Authors:  F W Verheggen; R Jonkers; G Kok
Journal:  Patient Educ Couns       Date:  1996-11

8.  Attitudes to randomized clinical trials amongst out-patients attending a medical oncology clinic.

Authors:  Peter M. Ellis; Sharon M. Dowsett; Phyllis N. Butow; Martin H.N. Tattersall
Journal:  Health Expect       Date:  1999-03       Impact factor: 3.377

9.  Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trial.

Authors:  K Featherstone; J L Donovan
Journal:  BMJ       Date:  1998-10-31

10.  "Why don't they just tell me straight, why allocate it?" The struggle to make sense of participating in a randomised controlled trial.

Authors:  Katie Featherstone; Jenny L Donovan
Journal:  Soc Sci Med       Date:  2002-09       Impact factor: 4.634

  10 in total
  16 in total

1.  Frontline ethical issues in pediatric clinical research: ethical and regulatory aspects of seven current bottlenecks in pediatric clinical research.

Authors:  Wim Pinxten; Herman Nys; Kris Dierickx
Journal:  Eur J Pediatr       Date:  2010-07-29       Impact factor: 3.183

2.  Randomized Controlled Trials 1: Design.

Authors:  Bryan M Curtis; Brendan J Barrett; Patrick S Parfrey
Journal:  Methods Mol Biol       Date:  2021

3.  "Hello, hello--it's English I speak!": a qualitative exploration of patients' understanding of the science of clinical trials.

Authors:  M Stead; D Eadie; D Gordon; K Angus
Journal:  J Med Ethics       Date:  2005-11       Impact factor: 2.903

4.  Comprehension of Randomization and Uncertainty in Cancer Clinical Trials Decision Making Among Rural, Appalachian Patients.

Authors:  Janice L Krieger; Angela Palmer-Wackerly; Phokeng M Dailey; Jessica L Krok-Schoen; Nancy E Schoenberg; Electra D Paskett
Journal:  J Cancer Educ       Date:  2015-12       Impact factor: 2.037

5.  Why do individuals agree to enrol in clinical trials? A qualitative study of health research participation in Blantyre, Malawi.

Authors:  Joseph Mfutso-Bengo; Paul Ndebele; Vincent Jumbe; Matilda Mkunthi; Francis Masiye; Sassy Molyneux; Malcolm Molyneux
Journal:  Malawi Med J       Date:  2008-06       Impact factor: 0.875

6.  The preferences of 600 patients for different descriptions of randomisation.

Authors:  V Jenkins; L Fallowfield; A Cox
Journal:  Br J Cancer       Date:  2005-03-14       Impact factor: 7.640

7.  Challenges for consent and community engagement in the conduct of cluster randomized trial among school children in low income settings: experiences from Kenya.

Authors:  George Okello; Caroline Jones; Maureen Bonareri; Sarah N Ndegwa; Carlos McHaro; Juddy Kengo; Kevin Kinyua; Margaret M Dubeck; Katherine E Halliday; Matthew C H Jukes; Sassy Molyneux; Simon J Brooker
Journal:  Trials       Date:  2013-05-16       Impact factor: 2.279

8.  The Patient Deficit Model Overturned: a qualitative study of patients' perceptions of invitation to participate in a randomized controlled trial comparing selective bladder preservation against surgery in muscle invasive bladder cancer (SPARE, CRUK/07/011).

Authors:  Clare Moynihan; Rebecca Lewis; Emma Hall; Emma Jones; Alison Birtle; Robert Huddart
Journal:  Trials       Date:  2012-11-29       Impact factor: 2.279

9.  Improving understanding of clinical trial procedures among low literacy populations: an intervention within a microbicide trial in Malawi.

Authors:  Paul M Ndebele; Douglas Wassenaar; Esther Munalula; Francis Masiye
Journal:  BMC Med Ethics       Date:  2012-11-08       Impact factor: 2.652

10.  Acceptability of cancer chemoprevention trials: impact of the design.

Authors:  Anne-Sophie Maisonneuve; Laetitia Huiart; Laetitia Rabayrol; Doug Horsman; Remi Didelot; Hagay Sobol; Francois Eisinger
Journal:  Int J Med Sci       Date:  2008-08-22       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.